Viekira Pak is FDA - approved for use in patients with genotype 1 chronic hepatitis C infection including those with
compensated cirrhosis.
Habu, D., Nishiguchi, S., Nakatani, S., Lee, C., Enomoto, M., Tamori, A., Takeda, T., Ohfuji, S., Fukushima, W., Tanaka, T., Kawamura, E., and Shiomi, S. Comparison of the effect of BCAA granules on between decompensated and
compensated cirrhosis.
The study analysed 1,815 adult Caucasians with CHB with or without
compensated cirrhosis and no hepatocellular carcinoma (HCC) at baseline who received ETV or TDF for at least 12 months.
Of these, 1,512 patients were treatment - naïve, 440 were treatment experienced and 224 had
compensated cirrhosis.
301 chronically infected adults were treated with the ravidasvir / sofosbuvir combination for 12 weeks for patients without cirrhosis of the liver, and for 24 weeks for those with
compensated cirrhosis.
Not exact matches
The results of this clinical trial showed cysteine, a metabolite of methionine metabolism, was «markedly reduced in patients with
compensated chronic liver disease, while in advanced
cirrhosis its concentration was within the normal range.»